Xionglin Fan
- Infectious Diseases top 2%
- Tuberculosis Research and Epidemiology 32
- SARS-CoV-2 and COVID-19 Research 10
- COVID-19 Clinical Research Studies 9
- Immunology top 5%
- Immunodeficiency and Autoimmune Disorders 18
- Immune responses and vaccinations 14
- Immunotherapy and Immune Responses 7
- Immune Response and Inflammation 7
- Neurology top 5%
- Epidemiology top 10%
- Mycobacterium research and diagnosis 12
- Co-authors
- Ellen J. HessH. A. JinnahVladimir NeychevVanio MitevYing ZhangChunwei ShiQing LeiYandi Zhang
- Journals
- SHILAP Revista de lepidopterología (2 papers)PLoS ONE (2 papers)Brain (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Xionglin Fan
55 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 106
- Infectious Diseases 636
- Immunology 430
- Neurology 235
- Cellular and Molecular Neuroscience 183
- Epidemiology 287
Countries citing papers authored by Xionglin Fan
This map shows the geographic impact of Xionglin Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xionglin Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xionglin Fan more than expected).
Fields of papers citing papers by Xionglin Fan
This network shows the impact of papers produced by Xionglin Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xionglin Fan. The network helps show where Xionglin Fan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xionglin Fan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 35 | |
| 5 | 2024 | 2 | |
| 6 | 2022 | 9 | |
| 7 | 2021 | 7 | |
| 8 | 2021 | 3 | |
| 9 | 2021 | 4 | |
| 10 | 2021 | 10 | |
| 11 | 2020 | 4 | |
| 12 | 2020 | 98 | |
| 13 | 2018 | 44 | |
| 14 | 2017 | 31 | |
| 15 | 2017 | 10 | |
| 16 | 2015 | 9 | |
| 17 | 2013 | 9 | |
| 18 | 2010 | 19 | |
| 19 | 2007 | 24 | |
| 20 | Gene vaccination of Mycobacterium tuberculosis DNA vaccine encoding mature form of Ag85B | 2001 | 1 |
About Xionglin Fan
Xionglin Fan is a scholar working on Infectious Diseases, Immunology and Epidemiology, having authored 58 papers that have together received 1.2k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (32 papers), Immunodeficiency and Autoimmune Disorders (18 papers), Immune responses and vaccinations (14 papers), Mycobacterium research and diagnosis (12 papers), SARS-CoV-2 and COVID-19 Research (10 papers), COVID-19 Clinical Research Studies (9 papers), Immunotherapy and Immune Responses (7 papers) and Immune Response and Inflammation (7 papers). The work is most often cited by research in Infectious Diseases (636 citations), Immunology (430 citations) and Neurology (235 citations). Xionglin Fan has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Ellen J. Hess, H. A. Jinnah, Vladimir Neychev, Vanio Mitev, Ying Zhang, Chunwei Shi, Qing Lei, Yandi Zhang, Qian Gao and Jia Lu. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Brain.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.